Wells Fargo’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.2K | Sell |
6,367
-53
| -0.8% | -$792 | ﹤0.01% | 4816 |
|
|
2025
Q1 | $75.2K | Buy |
6,420
+976
| +18% | +$11.4K | ﹤0.01% | 4791 |
|
|
2024
Q4 | $124K | Buy |
5,444
+1,397
| +35% | +$31.9K | ﹤0.01% | 4589 |
|
|
2024
Q3 | $170K | Buy |
4,047
+30
| +0.7% | +$1.26K | ﹤0.01% | 4297 |
|
|
2024
Q2 | $146K | Buy |
4,017
+3,546
| +753% | +$129K | ﹤0.01% | 4355 |
|
|
2024
Q1 | $24K | Buy |
471
+57
| +14% | +$2.9K | ﹤0.01% | 5147 |
|
|
2023
Q4 | $8.02K | Buy |
414
+1
| +0.2% | +$19 | ﹤0.01% | 5442 |
|
|
2023
Q3 | $6.53K | Buy |
413
+1
| +0.2% | +$16 | ﹤0.01% | 5534 |
|
|
2023
Q2 | $6.84K | Hold |
412
| – | – | ﹤0.01% | 5706 |
|
|
2023
Q1 | $5.76K | Buy |
412
+1
| +0.2% | +$14 | ﹤0.01% | 5696 |
|
|
2022
Q4 | $4.19K | Hold |
411
| – | – | ﹤0.01% | 5498 |
|
|
2022
Q3 | $5K | Hold |
411
| – | – | ﹤0.01% | 5580 |
|
|
2022
Q2 | $8K | Sell |
411
-162
| -28% | -$3.15K | ﹤0.01% | 5548 |
|
|
2022
Q1 | $22K | Sell |
573
-661
| -54% | -$25.4K | ﹤0.01% | 5637 |
|
|
2021
Q4 | $118K | Buy |
1,234
+755
| +158% | +$72.2K | ﹤0.01% | 5154 |
|
|
2021
Q3 | $69K | Sell |
479
-120
| -20% | -$17.3K | ﹤0.01% | 5219 |
|
|
2021
Q2 | $110K | Sell |
599
-146
| -20% | -$26.8K | ﹤0.01% | 4963 |
|
|
2021
Q1 | $184K | Sell |
745
-1,798
| -71% | -$444K | ﹤0.01% | 4875 |
|
|
2020
Q4 | $717K | Buy |
2,543
+85
| +3% | +$24K | ﹤0.01% | 4194 |
|
|
2020
Q3 | $591K | Sell |
2,458
-359
| -13% | -$86.3K | ﹤0.01% | 4125 |
|
|
2020
Q2 | $936K | Buy |
2,817
+2,805
| +23,375% | +$932K | ﹤0.01% | 3766 |
|
|
2020
Q1 | $3K | Buy |
+12
| New | +$3K | ﹤0.01% | 5626 |
|
|
2018
Q2 | – | Sell |
-184
| Closed | -$52K | – | 5989 |
|
|
2018
Q1 | $52K | Buy |
+184
| New | +$52K | ﹤0.01% | 5267 |
|
|
2016
Q4 | – | Sell |
-38
| Closed | -$10K | – | 5915 |
|
|
2016
Q3 | $10K | Buy |
+38
| New | +$10K | ﹤0.01% | 5448 |
|